Stoke Therapeutics
STOK
STOK
53 hedge funds and large institutions have $339M invested in Stoke Therapeutics in 2019 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 13 increasing their positions, 9 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
53
Holders Change
+6
Holders Change %
+12.77%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
25
Increased
13
Reduced
9
Closed
19
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$15.5M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.3M |
| 3 |
BlackRock
New York
|
+$12.3M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$9.91M |
| 5 |
Millennium Management
New York
|
+$3.12M |
Top Sellers
| 1 |
AI
Atom Investors
Austin,
Texas
|
-$5.82M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$5.62M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.45M |
| 4 |
O
OrbiMed
New York
|
-$3.79M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$2.91M |
